1-2 of 2
Michael Wittenberg
Close
Save search
Sort by
Journal Articles

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Free
Andreas Burchert, Susanne Saussele, Christian Michel, Stephan K Metzelder, Andreas Hochhaus, Norbert Gattermann, Martina Crysandt, Philippe Schafhausen, Matthias Bormann, Markus P. Radsak, Agnès Guerci-Bresler, Thomas Illmer, Maria E Goebeler, Peter Herhaus, Lino L. Teichmann, Georg-Nikolaus Franke, Fabian Lang, Stefan W. Krause, Robert Möhle, Martine Klausmann, Frank Stegelmann, Christoph Lutz, Gabriel Etienne, Andrea Stoltefuß, Joachim R Göthert, Thomas Ernst, Andreas Neubauer, Rüdiger Hehlmann, Behnaz Aminossadati, Michael Wittenberg, Markus Pfirrmann, Carmen Schade-Brittinger, Philipp le Coutre, Franck E. Nicolini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1501–1503.
https://doi.org/10.1182/blood-2022-169324
Published: 2022
Journal Articles

Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial

Free
Andreas Burchert, MD, Gesine Bug, Jürgen Finke, MD, Matthias Stelljes, MD, Christoph Rollig, MD MSC, Ralph Wäsch, MD, Martin Bornhäuser, Tobias Berg, MD, Fabian Lang, MD, Gerhard Ehninger, MD, Hubert Serve, MD, Robert Zeiser, MD, Eva-Maria Wagner, MD, Nicolaus Kroeger, Christine Wolschke, MD, Michael Schleuning, MD, Ahmet Elmaagacli, Katharina S. Götze, MD, Christoph Schmid, MD, Edgar Jost, MD, Dominik Wolf, Alexandra Böhm, MD, Christian Thiede, MD, Torsten Haferlach, MD, Wolfgang Bethge, MD, Susanne Harnisch, Dipl. Humanbiol., Michael Wittenberg, PhD, Susanne Rospleszcz, Andreas Neubauer, Markus Brugger, Konstantin Strauch, PhD, Carmen Schade-Brittinger, Stephan K Metzelder, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 661.
https://doi.org/10.1182/blood-2018-99-112614
Published: 2018